NB
Naresh Bansilal Shah
About Naresh Bansilal Shah
Data last updated:
Naresh Bansilal Shah is a Director at Senores Pharmaceuticals Limited (since 2024). The company operates in Pharma. Senores Pharmaceuticals Limited reported revenue of ₹418 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Senores Pharmaceuticals Limited L24290GJ2017PLC100263 | Director | 30 Jan 2024 | 2017 | ₹418 Cr (FY 2025) | Active |
Board colleagues of Naresh Bansilal Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arpit Deepakkumar Shah | 07214641 | Senores Pharmaceuticals Limited | Director |
| Ashokkumar Vijaysinh Barot | 01192300 | Senores Pharmaceuticals Limited | Director |
| Chetan Bipinchandra Shah | 10381971 | Senores Pharmaceuticals Limited | Whole-Time Director |
| Deval Rajnikant Shah | 00332722 | Senores Pharmaceuticals Limited | Whole-Time Director |
| Deval Rajnikant Shah | Senores Pharmaceuticals Limited | Cfo | |
| Hemanshu Nitinchandra Pandya | 10383995 | Senores Pharmaceuticals Limited | Director |
| Jitendra Babulal Sanghvi | 00271995 | Senores Pharmaceuticals Limited | Director |
| Kalpit Rajesh Gandhi | 02843308 | Senores Pharmaceuticals Limited | Director |
| Manjula Devi Shroff | 00297159 | Senores Pharmaceuticals Limited | Director |
| Sanjay Shaileshbhai Majmudar | 00091305 | Senores Pharmaceuticals Limited | Director |
| Swapnil Jatinbhai Shah | 05259821 | Senores Pharmaceuticals Limited | Managing Director |
| Udayan Dileep Choksi | 02222020 | Senores Pharmaceuticals Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naresh Bansilal Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naresh Bansilal Shah
Naresh Bansilal Shah currently holds 1 directorship: Senores Pharmaceuticals Limited (Director, since 30 Jan 2024, revenue ₹418 Cr (FY 2025)).
Naresh Bansilal Shah was first appointed on 30 Jan 2024 as Director at Senores Pharmaceuticals Limited.
The current boards of Naresh Bansilal Shah's companies include Arpit Deepakkumar Shah (Senores Pharmaceuticals Limited), Ashokkumar Vijaysinh Barot (Senores Pharmaceuticals Limited), Chetan Bipinchandra Shah (Senores Pharmaceuticals Limited), Deval Rajnikant Shah (Senores Pharmaceuticals Limited), Deval Rajnikant Shah (Senores Pharmaceuticals Limited), Hemanshu Nitinchandra Pandya (Senores Pharmaceuticals Limited), among others.